McBreen Michael J. 4

What Happened

• Michael J. McBreen, EVP & President, CSS of Integra Lifesciences (IART), received a grant of 92,108 restricted stock units (RSUs) on 2026-03-11 and had a total of 9,601 shares disposed (withheld/sold) to satisfy tax/price obligations around the same time. The withheld shares were 2,354 at $9.55 on 2026-03-10 ($22,481) and 7,247 at $9.61 on 2026-03-11 ($69,644), totaling $92,125. The RSU grant is recorded as acquired at $0.00 because it’s a time‑based award (derivative).

Key Details

• Transaction dates and prices:
  • 2026-03-10: 2,354 shares disposed at $9.55 — $22,481 (code F: payment of exercise price or tax liability)
  • 2026-03-11: 7,247 shares disposed at $9.61 — $69,644 (code F)
  • 2026-03-11: Grant of 92,108 RSUs (code A, acquired at $0.00)
• Total shares disposed for tax/price: 9,601 shares for $92,125.
• Shares owned after the transactions: not specified in the information provided in this summary (check the full Form 4 for "Amount Owned Following Reported Transaction" if needed).
• Footnote: The RSU award vests 33% on the first and second anniversaries and 34% on the third anniversary of the grant date (3/11/2026).
• Filing timeliness: Form filed 2026-03-12 for transactions on 3/10–3/11 — appears to be filed timely (no late‑filing flag provided).

Context

• Code F indicates these disposals were to satisfy an exercise price or tax withholding obligation (common with option exercises or RSU settlements) rather than open‑market sales; such withholdings are routine and do not necessarily signal a view on the stock.
• The RSUs are time‑based and subject to multi‑year vesting; the award does not represent immediately liquid shares.
• No 10b5-1 plan or other special sale program is indicated in the provided details.